Apotex Health Company Description
Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India.
The company develops, manufactures, and distributes a broad portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products.
It operates through three business lines including conventional generic pharmaceuticals; specialty generic pharmaceuticals; and brands & biosimilars.
The company has a a strategic partnership with Halo Pharmaceutical, Inc. The company was formerly known as Artemis Parent, Inc. and changed its name to Apotex Health Corp. in May 2026.
Apotex Health Corp. was founded in 1974 and is headquartered in Toronto, Canada. Apotex Health Corp. operates as a subsidiary of SK Artemis Holdings, II, LLC
| Country | Canada |
| Founded | 1974 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 6,216 |
| CEO | Jeff Watson |
Contact Details
Address: 150 Signet Drive Toronto, ON M9L 1T9 Canada | |
| Phone | (800) 268-4623 |
| Website | apotex.com |
Stock Details
| Ticker Symbol | APTX |
| Exchange | Toronto Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | CAD |
| ISIN Number | CA03772D1015 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jeff Watson | President, Chief Executive Officer and Director |
| Brian McClelland | Chief Financial Officer |
| Ariel Alon | Chief Operating Officer |
| Francesco Tallarico | Chief Legal Officer and Global Head of Government Relations |
| Barry Fishman | Chief Corporate Development Officer |
| Carina Vassilieva C.C.P., G.R.P., M.B.A. | Chief Human Resources Officer |
| Dr. Kiran Krishnan Ph.D. | Senior Vice President of Global Regulatory Affairs |
| Martin Arès | President of Canada and Rest of World |
| Christine Baeder | President of Apotex USA and LATAM |
| Dr. Pradeep Sanghvi | Executive Vice President of Global Research and Development |